Literature DB >> 24727567

Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy.

Beatriz Garcia-Diaz1, Caterina Garone, Emanuele Barca, Hamed Mojahed, Purification Gutierrez, Giuseppe Pizzorno, Kurenai Tanji, Fernando Arias-Mendoza, Caterina M Quinzii, Michio Hirano.   

Abstract

Balanced pools of deoxyribonucleoside triphosphate precursors are required for DNA replication, and alterations of this balance are relevant to human mitochondrial diseases including mitochondrial neurogastrointestinal encephalopathy. In this disease, autosomal recessive TYMP mutations cause severe reductions of thymidine phosphorylase activity; marked elevations of the pyrimidine nucleosides thymidine and deoxyuridine in plasma and tissues, and somatic multiple deletions, depletion and site-specific point mutations of mitochondrial DNA. Thymidine phosphorylase and uridine phosphorylase double knockout mice recapitulated several features of these patients including thymidine phosphorylase activity deficiency, elevated thymidine and deoxyuridine in tissues, mitochondrial DNA depletion, respiratory chain defects and white matter changes. However, in contrast to patients with this disease, mutant mice showed mitochondrial alterations only in the brain. To test the hypothesis that elevated levels of nucleotides cause unbalanced deoxyribonucleoside triphosphate pools and, in turn, pathogenic mitochondrial DNA instability, we have stressed double knockout mice with exogenous thymidine and deoxyuridine, and assessed clinical, neuroradiological, histological, molecular, and biochemical consequences. Mutant mice treated with exogenous thymidine and deoxyuridine showed reduced survival, body weight, and muscle strength, relative to untreated animals. Moreover, in treated mutants, leukoencephalopathy, a hallmark of the disease, was enhanced and the small intestine showed a reduction of smooth muscle cells and increased fibrosis. Levels of mitochondrial DNA were depleted not only in the brain but also in the small intestine, and deoxyribonucleoside triphosphate imbalance was observed in the brain. The relative proportion, rather than the absolute amount of deoxyribonucleoside triphosphate, was critical for mitochondrial DNA maintenance. Thus, our results demonstrate that stress of exogenous pyrimidine nucleosides enhances the mitochondrial phenotype of our knockout mice. Our mouse studies provide insights into the pathogenic role of thymidine and deoxyuridine imbalance in mitochondrial neurogastrointestinal encephalopathy and an excellent model to study new therapeutic approaches.

Entities:  

Keywords:  MNGIE; animal model; deoxynucleotide; deoxyuridine; mitochondrial DNA; thymidine

Mesh:

Substances:

Year:  2014        PMID: 24727567      PMCID: PMC3999724          DOI: 10.1093/brain/awu068

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  43 in total

1.  Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations.

Authors:  I Nishino; A Spinazzola; A Papadimitriou; S Hammans; I Steiner; C D Hahn; A M Connolly; A Verloes; J Guimarães; I Maillard; H Hamano; M A Donati; C E Semrad; J A Russell; A L Andreu; G M Hadjigeorgiou; T H Vu; S Tadesse; T G Nygaard; I Nonaka; I Hirano; E Bonilla; L P Rowland; S DiMauro; M Hirano
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

2.  The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA.

Authors:  H Mandel; R Szargel; V Labay; O Elpeleg; A Saada; A Shalata; Y Anbinder; D Berkowitz; C Hartman; M Barak; S Eriksson; N Cohen
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

3.  Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase.

Authors:  C Desgranges; G Razaka; M Rabaud; H Bricaud
Journal:  Biochim Biophys Acta       Date:  1981-07-27

4.  Altered thymidine metabolism due to defects of thymidine phosphorylase.

Authors:  Antonella Spinazzola; Ramon Marti; Ichizo Nishino; Antonio L Andreu; Ali Naini; Saba Tadesse; Ivana Pela; Enrico Zammarchi; M Alice Donati; Juan A Oliver; Michio Hirano
Journal:  J Biol Chem       Date:  2001-12-03       Impact factor: 5.157

5.  Identification of a novel human uridine phosphorylase.

Authors:  Magnus Johansson
Journal:  Biochem Biophys Res Commun       Date:  2003-07-18       Impact factor: 3.575

Review 6.  Alteration of nucleotide metabolism: a new mechanism for mitochondrial disorders.

Authors:  Ramon Martí; Yutaka Nishigaki; Maya R Vilá; Michio Hirano
Journal:  Clin Chem Lab Med       Date:  2003-07       Impact factor: 3.694

7.  Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays.

Authors:  Ramon Martí; Antonella Spinazzola; Saba Tadesse; Ichizo Nishino; Yutaka Nishigaki; Michio Hirano
Journal:  Clin Chem       Date:  2003-11-18       Impact factor: 8.327

8.  Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA.

Authors:  Shiwei Song; Linda J Wheeler; Christopher K Mathews
Journal:  J Biol Chem       Date:  2003-09-17       Impact factor: 5.157

9.  Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency.

Authors:  Yutaka Nishigaki; Ramon Martí; William C Copeland; Michio Hirano
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  ND5 is a hot-spot for multiple atypical mitochondrial DNA deletions in mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Yutaka Nishigaki; Ramon Marti; Michio Hirano
Journal:  Hum Mol Genet       Date:  2003-11-12       Impact factor: 6.150

View more
  10 in total

1.  Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade.

Authors:  Hanying Wang; Xin He; Lei Zhang; Haojie Dong; Feiteng Huang; Jie Xian; Min Li; Wei Chen; Xiyuan Lu; Khyatiben V Pathak; Wenfeng Huang; Zheng Li; Lianjun Zhang; Le Xuan Truong Nguyen; Lu Yang; Lifeng Feng; David J Gordon; Jing Zhang; Patrick Pirrotte; Chun-Wei Chen; Amandeep Salhotra; Ya-Huei Kuo; David Horne; Guido Marcucci; David B Sykes; Stefano Tiziani; Hongchuan Jin; Xian Wang; Ling Li
Journal:  Blood       Date:  2022-06-30       Impact factor: 25.476

Review 2.  AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives.

Authors:  Allison R Hanaford; Yoon-Jae Cho; Hiroyuki Nakai
Journal:  Orphanet J Rare Dis       Date:  2022-06-06       Impact factor: 4.303

3.  Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalomyopathy.

Authors:  Javier Torres-Torronteras; Raquel Cabrera-Pérez; Ignasi Barba; Carme Costa; Noemí de Luna; Antoni L Andreu; Jordi Barquinero; Michio Hirano; Yolanda Cámara; Ramon Martí
Journal:  Hum Gene Ther       Date:  2016-05-04       Impact factor: 5.695

4.  Transient clinical improvement of a mitochondrial neurogastrointestinal encephalomyopathy-like syndrome after allogeneic haematopoietic stem cell transplantation.

Authors:  Malcolm Kevin Baker; Clara Maria Schutte; Neelay Ranchhod; David Brittain; J E van Rensburg
Journal:  BMJ Case Rep       Date:  2017-08-01

5.  Long-Term Sustained Effect of Liver-Targeted Adeno-Associated Virus Gene Therapy for Mitochondrial Neurogastrointestinal Encephalomyopathy.

Authors:  Javier Torres-Torronteras; Raquel Cabrera-Pérez; Ferran Vila-Julià; Carlo Viscomi; Yolanda Cámara; Michio Hirano; Massimo Zeviani; Ramon Martí
Journal:  Hum Gene Ther       Date:  2018-02-26       Impact factor: 4.793

Review 6.  Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.

Authors:  Rana Yadak; Peter Sillevis Smitt; Marike W van Gisbergen; Niek P van Til; Irenaeus F M de Coo
Journal:  Front Cell Neurosci       Date:  2017-02-15       Impact factor: 5.505

Review 7.  Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far.

Authors:  Dario Pacitti; Michelle Levene; Caterina Garone; Niranjanan Nirmalananthan; Bridget E Bax
Journal:  Front Genet       Date:  2018-12-21       Impact factor: 4.599

8.  Efficacy of adeno-associated virus gene therapy in a MNGIE murine model enhanced by chronic exposure to nucleosides.

Authors:  Ferran Vila-Julià; Raquel Cabrera-Pérez; Yolanda Cámara; Miguel Molina-Berenguer; Silvia Lope-Piedrafita; Michio Hirano; Federico Mingozzi; Javier Torres-Torronteras; Ramon Martí
Journal:  EBioMedicine       Date:  2020-11-21       Impact factor: 8.143

9.  Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes.

Authors:  Jérémie Gautheron; Lara Lima; Baris Akinci; Jamila Zammouri; Martine Auclair; Sema Kalkan Ucar; Samim Ozen; Canan Altay; Bridget E Bax; Ivan Nemazanyy; Véronique Lenoir; Carina Prip-Buus; Cécile Acquaviva-Bourdain; Olivier Lascols; Bruno Fève; Corinne Vigouroux; Esther Noel; Isabelle Jéru
Journal:  BMC Med       Date:  2022-03-28       Impact factor: 8.775

Review 10.  Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective.

Authors:  Alessia Di Donfrancesco; Giulia Massaro; Ivano Di Meo; Valeria Tiranti; Emanuela Bottani; Dario Brunetti
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.